Table 2.
RE-AIM construct | Evaluation measuresa | Washington University Siteman Cancer Center | Yale University Smilow Cancer Hospital | Case Western Reserve University Case Comprehensive Cancer Centerc | |
---|---|---|---|---|---|
REACH | Smoking prevalenceb | 12.5% | 18% | 21.1% | |
Smokers reached with at least one evidence-based cessation treatment | 43.1% of smokers were prescribed cessation medications and/or received brief counseling at the point-of-care | 7% of smokers were prescribed cessation medications, referred to the TTS, and/or referred to SmokefreeTXT | 24.3% of smokers were prescribed cessation medications, referred to TIPS, and/or referred to SmokefreeTXT | ||
EFFECTIVENESS | Assessment method | Tobacco use status from EHR for most recent visit during 6-months period post-treatment | Assessed at 6-months in person or via phone & documented in EHR | Assessed at 6-months in person or via phone and documented in EHR. | |
6-month follow-up rate | 67.2% | 13.5% | 54.4% | ||
30-day point prevalence abstinence | Counting patients lost to follow-up as smokers | 29.5% | 2.2% | 19.5%, | |
Among patients with follow-up data | 43.9% | 16.7% | 35.1% | ||
ADOPTION | Setting level adoption | 21/21 outpatient oncology clinics over a 6-months implementation period. | Adopted at Smilow Cancer Center and 9/10 Care Centers over ~8 months. | Adopted in 3/3 healthcare systems. One launched center-wide, two launched in thoracic and gynecological oncology clinics. | |
Provider level adoption | 99% providers initiated assessment, 79% initiated documentation of medication, 85% initiated offer of counseling referral. | Not assessed | Number of referring providers (N = 64) has increased by 25% over 1 year of implementation. | ||
IMPLEMENTATION | Setting level tobacco use assessment rate | 93% | 49.5% | 80% | |
Provider-level tobacco use assessment rate | 93% providers achieved ≥90% rate | Not assessed | Not assessed | ||
Implementation of key program components | Pharmacotherapy rate: 49% of providers achieve ≥20% rate; Counseling offer rate: 51% of providers achieve ≥50% rate | BPA utilization rates for referrals to the TTS, pharmacotherapy or both. | 51% of referred patients received at least one component of the TIPS intervention. | ||
MAINTENANCE | Sustainability plans/goals |
• 6-months ongoing reach and effectiveness evaluation. • Incentivize care using data transparency and performance feedback. • Low-burden, low cost decision support tool for point-of-care use ($3 per patient). |
Hiring another tobacco treatment specialist to maintain program at Care Centers. Billing for services using an APRN and expanding telehealth services. Integrating referrals into new patient onboarding by nurse navigators. |
• Leverage initial success. • Generate new funding sources. • Reduce patient barriers to treatment (e.g. cost, transportation. • Identify 100% of smokers & reach at least 50% of smokers with treatment. |
Reported for a 6-month period at 1-year post-implementation.
Among patients screened for tobacco use.
Average of three cancer healthcare settings.
TTS, Tobacco Treatment Service; TIPS, Tobacco Intervention & Psychosocial Support.